| Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 71701* | 2013 |
| 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure P Ponikowski, AA Voors, SD Anker, H Bueno, JGF Cleland, AJS Coats, ... Kardiologia Polska (Polish Heart Journal) 74 (10), 1037-1147, 2016 | 25254 | 2016 |
| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 13032 | 2021 |
| Apixaban versus warfarin in patients with atrial fibrillation CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ... New England Journal of Medicine 365 (11), 981-992, 2011 | 11438 | 2011 |
| HFSA 2010 comprehensive heart failure practice guideline. J Lindenfeld, NM Albert, JP Boehmer, SP Collins, JA Ezekowitz, ... Journal of cardiac failure 16 (6), e1-194, 2010 | 2716* | 2010 |
| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1489 | 2011 |
| Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure JA Ezekowitz, FA McAlister, PW Armstrong Circulation 107 (2), 223-225, 2003 | 1376 | 2003 |
| Vericiguat in patients with heart failure and reduced ejection fraction PW Armstrong, B Pieske, KJ Anstrom, J Ezekowitz, AF Hernandez, ... New England Journal of Medicine 382 (20), 1883-1893, 2020 | 1234 | 2020 |
| Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study FA McAlister, J Ezekowitz, M Tonelli, PW Armstrong Circulation 109 (8), 1004-1009, 2004 | 1014 | 2004 |
| The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) European heart journal 33 (14), 1750-1757, 2012 | 958 | 2012 |
| 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure JA Ezekowitz, E O'Meara, MA McDonald, H Abrams, M Chan, ... Canadian Journal of Cardiology 33 (11), 1342-1433, 2017 | 856 | 2017 |
| Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review FA McAlister, J Ezekowitz, N Hooton, B Vandermeer, C Spooner, ... Jama 297 (22), 2502-2514, 2007 | 798 | 2007 |
| Meta-analysis: β-blocker dose, heart rate reduction, and death in patients with heart failure FA McAlister, N Wiebe, JA Ezekowitz, AA Leung, PW Armstrong Annals of Internal Medicine 150 (11), 784-794, 2009 | 754 | 2009 |
| Semaglutide in patients with heart failure with preserved ejection fraction and obesity MN Kosiborod, SZ Abildstrøm, BA Borlaug, J Butler, S Rasmussen, ... New England Journal of Medicine 389 (12), 1069-1084, 2023 | 682 | 2023 |
| Effect of natriuretic peptide–guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized … GM Felker, KJ Anstrom, KF Adams, JA Ezekowitz, M Fiuzat, ... Jama 318 (8), 713-720, 2017 | 534 | 2017 |
| Systematic review: cardiac resynchronization in patients with symptomatic heart failure FA McAlister, JA Ezekowitz, N Wiebe, B Rowe, C Spooner, E Crumley, ... Annals of internal medicine 141 (5), 381-390, 2004 | 492 | 2004 |
| The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease J Ezekowitz, FA McAlister, KH Humphries, CM Norris, M Tonelli, WA Ghali, ... Journal of the American College of Cardiology 44 (8), 1587-1592, 2004 | 482 | 2004 |
| Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction JA Ezekowitz, P Kaul, JA Bakal, PW Armstrong, RC Welsh, FA McAlister Journal of the American College of Cardiology 53 (1), 13-20, 2009 | 464 | 2009 |
| Multidisciplinary approach to novel therapies in cardio-oncology research (MANTICORE 101–Breast): a randomized trial for the prevention of trastuzumab-associated cardiotoxicity E Pituskin, JR Mackey, S Koshman, D Jassal, M Pitz, MJ Haykowsky, ... Journal of clinical oncology 35 (8), 870-877, 2017 | 418 | 2017 |
| Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials JA Ezekowitz, PW Armstrong, FA McAlister Annals of internal medicine 138 (6), 445-452, 2003 | 372 | 2003 |
Finlay McAlisterProfessor, University of AlbertaVerificeret mail på ualberta.ca
